EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 33 / No 4 (Avril 2017) Med Sci (Paris), 33 4 (2017) 417-422 References
Free Access
Issue
Med Sci (Paris)
Volume 33, Number 4, Avril 2017
Page(s) 417 - 422
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20173304012
Published online 12 May 2017
  1. Veldhuis-Vlug AG, Fliers E, Bisschop PH. Bone as a regulator of glucose metabolism. Neth J Med 2013 ; 71 : 396–400. [PubMed] [Google Scholar]
  2. Confavreux CB, Ferron M. Le diabète est tombé sur un os… Med Sci (Paris) 2008 ; 24 : 21–23. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  3. Ferron M, Lacombe J. Regulation of energy metabolism by the skeleton: osteocalcin and beyond. Arch Biochem Biophys 2014 ; 561 : 137–146. [CrossRef] [PubMed] [Google Scholar]
  4. Shao J, Wang Z, Yang T, et al. Bone regulates glucose metabolism as an endocrine organ through osteocalcin. Int J Endocrinol 2015 ; 2015 : 967673. [CrossRef] [PubMed] [Google Scholar]
  5. Marie P. Différenciation, fonction et contrôle de l’ostéoblaste. Med Sci (Paris) 2001 ; 17 : 1252–1259. [CrossRef] [EDP Sciences] [Google Scholar]
  6. Booth SL, Centi A, Smith SR, Gundberg C. The role of osteocalcin in human glucose metabolism: marker or mediator? Nat Rev Endocrinol 2013 ; 9 : 43–55. [CrossRef] [PubMed] [Google Scholar]
  7. Ducy P, Desbois C, Boyce B, et al. Increased bone formation in osteocalcin-deficient mice. Nature 1996 ; 382 : 448–452. [CrossRef] [PubMed] [Google Scholar]
  8. Oury F, Sumara G, Sumara O, et al. Endocrine regulation of male fertility by the skeleton. Cell 2011 ; 144 : 796–809. [CrossRef] [PubMed] [Google Scholar]
  9. Oury F, Ferron M, Huizhen W, et al. Osteocalcin regulates murine and human fertility through a pancreas-bone-testis axis. J Clin Invest 2013 ; 123 : 2421–2433. [CrossRef] [PubMed] [Google Scholar]
  10. Oury F, Khrimian L, Denny CA, et al. Maternal and offspring pools of osteocalcin influence brain development and functions. Cell 2013 ; 155 : 228–241. [CrossRef] [PubMed] [Google Scholar]
  11. Brennan-Speranza TC, Henneicke H, Gasparini SJ, et al. Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism. J Clin Invest 2012 ; 122 : 4172–4189. [CrossRef] [PubMed] [Google Scholar]
  12. Levinger I, Jerums G, Stepto NK, et al. The effect of acute exercise on undercarboxylated osteocalcin and insulin sensitivity in obese men. J Bone Miner Res 2014 ; 29 : 2571–2576. [CrossRef] [PubMed] [Google Scholar]
  13. Hill HS, Grams J, Walton RG, et al. Carboxylated and uncarboxylated forms of osteocalcin directly modulate the glucose transport system and inflammation in adipocytes. Horm Metab Res 2014 ; 46 : 341–347. [CrossRef] [PubMed] [Google Scholar]
  14. Lee NK, Sowa H, Hinoi E, et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007 ; 130 : 456–469. [CrossRef] [PubMed] [Google Scholar]
  15. Wei J, Karsenty G. An overview of the metabolic functions of osteocalcin. Rev Endocr Metab Disord 2015 ; 16 : 93–98. [CrossRef] [Google Scholar]
  16. Ferron M, Wei J, Yoshizawa T, et al. Insulin signaling in osteoblasts integrates bone remodeling and energy metabolism. Cell 2010 ; 142 : 296–308. [CrossRef] [PubMed] [Google Scholar]
  17. Kanazawa I, Yamaguchi T, Yamauchi M, et al. Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus. Osteoporos Int 2011 ; 22 : 187–194. [CrossRef] [PubMed] [Google Scholar]
  18. Im JA, Yu BP, Jeon JY, Kim SH. Relationship between osteocalcin and glucose metabolism in postmenopausal women. Clin Chim Acta 2008 ; 396 : 66–69. [CrossRef] [Google Scholar]
  19. Takaya J, Tanabe Y, Kuroyanagi Y, Kaneko K. Decreased undercarboxylated osteocalcin in children with type 2 diabetes mellitus. J Pediatr Endocrinol Metab 2016 ; 29 : 879–884. [CrossRef] [PubMed] [Google Scholar]
  20. Neumann T, Lodes S, Kastner B, et al. Osteocalcin, adipokines and their associations with glucose metabolism in type 1 diabetes. Bone 2016 ; 82 : 50–55. [CrossRef] [PubMed] [Google Scholar]
  21. Gower BA, Pollock NK, Casazza K, et al. Associations of total and undercarboxylated osteocalcin with peripheral and hepatic insulin sensitivity and beta-cell function in overweight adults. J Clin Endocrinol Metab 2013 ; 98 : E1173–E1180. [CrossRef] [PubMed] [Google Scholar]
  22. Fernandez-Real JM, Izquierdo M, Ortega F, et al. The relationship of serum osteocalcin concentration to insulin secretion, sensitivity, and disposal with hypocaloric diet and resistance training. J Clin Endocrinol Metab 2009 ; 94 : 237–245. [CrossRef] [PubMed] [Google Scholar]
  23. Reinehr T, Roth CL. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond) 2010 ; 34 : 852–858. [CrossRef] [PubMed] [Google Scholar]
  24. Rochefort GY, Rocher E, Aveline PC, et al. Osteocalcin-insulin relationship in obese children: a role for the skeleton in energy metabolism. Clin Endocrinol (Oxf) 2011 ; 75 : 265–270. [CrossRef] [PubMed] [Google Scholar]
  25. Alberti KG, Zimmet P, Shaw J. Group IDFETFC. The metabolic syndrome: a new worldwide definition. Lancet 2005 ; 366 : 1059–1062. [Google Scholar]
  26. Lee SW, Jo HH, Kim MR, et al. Association between osteocalcin and metabolic syndrome in postmenopausal women. Arch Gynecol Obstet 2015 ; 292 : 673–681. [CrossRef] [PubMed] [Google Scholar]
  27. Saleem U, Mosley TH, Jr, Kullo IJ. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol 2010 ; 30 : 1474–1478. [CrossRef] [PubMed] [Google Scholar]
  28. Hwang YC, Kang M, Cho IJ, et al. Association between the circulating total osteocalcin level and the development of cardiovascular disease in middle-aged men: a mean 8.7-year longitudinal follow-up study. J Atheroscler Thromb 2015 ; 22 : 136–143. [CrossRef] [PubMed] [Google Scholar]
  29. Du J, Pan X, Lu Z, et al. Serum osteocalcin levels are inversely associated with the presence of nonalcoholic fatty liver disease in patients with coronary artery disease. Int J Clin Exp Med 2015 ; 8 : 21435–21441. [Google Scholar]
  30. Yang HJ, Shim SG, Ma BO, Kwak JY. Association of nonalcoholic fatty liver disease with bone mineral density and serum osteocalcin levels in Korean men. Eur J Gastroenterol Hepatol 2016 ; 28 : 338–344. [CrossRef] [PubMed] [Google Scholar]
  31. Luo YQ, Ma XJ, Hao YP, et al. Inverse relationship between serum osteocalcin levels and nonalcoholic fatty liver disease in postmenopausal Chinese women with normal blood glucose levels. Acta Pharmacol Sin 2015 ; 36 : 1497–1502. [CrossRef] [PubMed] [Google Scholar]
  32. Sinn DH, Gwak GY, Rhee SY, et al. Association between serum osteocalcin levels and non-alcoholic fatty liver disease in women. Digestion 2015 ; 91 : 150–157. [CrossRef] [PubMed] [Google Scholar]
  33. Ferron M, Hinoi E, Karsenty G, Ducy P. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci USA 2008 ; 105 : 5266–5270. [CrossRef] [Google Scholar]
  34. Ferron M, McKee MD, Levine RL, et al. Intermittent injections of osteocalcin improve glucose metabolism and prevent type 2 diabetes in mice. Bone 2012 ; 50 : 568–575. [CrossRef] [PubMed] [Google Scholar]
  35. Mizokami A, Yasutake Y, Gao J, et al. Osteocalcin induces release of glucagon-like peptide-1 and thereby stimulates insulin secretion in mice. PLoS One 2013 ; 8 : e57375. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.